In the present study, we revealed that the multi-target mechanism of fisetin inhibits melanogenesis in human melanoma cells by promoting the degradation of β-catenin via activation of PKCα, leading to a reduction in MITF expression and stability through activation of the ERK signaling pathway. The gene discussed is PRKCA; the disease is melanoma.